Download January to April 2009 - MRC Clinical Trials Unit

Title
Author
Journal
Stable frequency of HIV-1 transmitted
drug resistance in patients at the time of
primary infection over 1996-2006 in
France
Chaix, Marie-Laure
AIDS - March 2009, Volume 23, Issue 6
Dynamic patterns of human
immunodeficiency virus type 1
integrase gene evolution in patients
failing raltegravir-based salvage
therapies
Lazzarin, Adriano
AIDS - February 2008, Volume 23, Issue 4
A randomized trial of therapeutic drug
monitoring of protease inhibitors in
antiretroviral-experienced, HIV-1infected patients
Demeter, Lisa M
AIDS - January 2009, Volume 23, Issue 3
A public health model for the molecular
surveillance of HIV transmission in San
Diego, California
Smith, Davey
AIDS - January 2009, Volume 23, Issue 2
Antiretroviral combinations implicated
in emergence of the L74I and L74V
resistance mutations in HIV-1-infected
patients
Wirden, Marc
AIDS - January 2009, Volume 23, Issue 1
Transmission networks of drug
resistance acquired in primary/early
stage HIV infection
Brenner, Bluma G
AIDS - November 2008, Volume 22, Issue
18
Silent mutations are selected in HIV-1
reverse transcriptase and affect
enzymatic efficiency
Harrigan, P Richard
AIDS - November 2008, Volume 22, Issue
18
Viral resuppression and detection of
drug resistance following interruption of
a suppressive non-nucleoside reverse
transcriptase inhibitor-based regimen
Fox, Zoe
AIDS - November 2008, Volume 22, Issue
17
Differential impact of adherence on
long-term treatment response among
naive HIV-infected individuals
Lima, Viviane
AIDS - November 2008, Volume 22, Issue
17
Phenotypic impact of resistance
mutations on etravirine susceptibility in
HIV patients with prior failure to
nonnucleoside analogues
Poveda, Eva
AIDS - November 2008, Volume 22, Issue
17
Bayesian network analyses of
resistance pathways against efavirenz
and nevirapine
Deforche, Koena
AIDS - October 2008, Volume 22, Issue 16
Detection of HIV drug resistance during
antiretroviral treatment and clinical
progression in a large European cohort
study
Cozzi-Lepri, Alessandro
AIDS - October 2008, Volume 22, Issue 16
Prevalence of Nevirapine-Associated
Resistance Mutations after Single Dose
Prophylactic Treatment among
Antenatal Clinic Attendees in North Rift
Kenya
Michael Kiptoo
AIDS Research and Human Retroviruses volume 24, Issue 12
Appreciating HIV Type 1 Diversity:
Subtype Differences in Env
Rebecca M. Lynch
AIDS Research and Human Retroviruses March 2009, Volume 25, Issue 3
Virological Suppression Reduces
Clinical Progression in Patients with
Multiclass-Resistant HIV Type 1
Laura Bracciale
AIDS Research and Human Retroviruses March 2009, Volume 25, Issue 3
A Comparison of Interpretation by Three
Different HIV Type 1 Genotypic Drug
Resistance Algorithms Using
Sequences from Non-Clade B HIV Type
1 Strains
Abraham Joseph
Kandathil
AIDS Research and Human Retroviruses March 2009, Volume 25, Issue 3
The Changing Trend of HIV Type 1
Subtypes in Nairobi
Raphael W. Lihana
AIDS Research and Human Retroviruses March 2009, Volume 25, Issue 3
Analysis of pol Integrase Sequences in
Diverse HIV Type 1 Strains Using a
Prototype Genotyping Assay
Susan H. Eshleman
AIDS Research and Human Retroviruses March 2009, Volume 25, Issue 3
Non-B HIV Type 1 Subtypes among Men
Who Have Sex with Men in Rome, Italy
M. Giuliani
AIDS Research and Human Retroviruses February 2009, Volume 25, Issue 2
Enfuvirtide (T-20) Resistance-Related
Mutations in HIV Type 1 Subtypes B, C,
and F Isolates from Brazilian Patients
Failing HAART
A.C.A. Oliveira
AIDS Research and Human Retroviruses February 2009, Volume 25, Issue 2
Genotypic Characterization of
CRF01_AE env Genes Derived from
Human Immunodeficiency Virus Type 1Infected Patients Residing in Central
Thailand
Piraporn Utachee
AIDS Research and Human Retroviruses Volume 25, Issue 1
Non-B HIV Type 1 Subtypes among Men
Who Have Sex with Men in Rome, Italy
M Giuliani
AIDS Research and Human Retroviruses Volume 25, Issue 1
Molecular Phylogenetics of Nearly FullLength HIV Type 2 envelope Gene
Sequences from West India
Sushama Jadhav
AIDS Research and Human Retroviruses Volume 25, Issue 1
An 11-Year Surveillance of HIV Type 1
Subtypes in Nagoya, Japan
Seiichiro Fujisaki
AIDS Research and Human Retroviruses Volume 25, Issue 1
Genetic Analysis of HIV Type 1 Strains
from Newly Infected Untreated Patients
in Cyprus: High Genetic Diversity and
Low Prevalence of Drug Resistance
Ioanna Kousiappa
AIDS Research and Human Retroviruses Volume 25, Issue 1
Identification and Characterization of
CRF02_AG, CRF06_cpx, and
CRF09_cpx Recombinant Subtypes in
Mali, West Africa
Hiromi Imamichi
AIDS Research and Human Retroviruses Volume 25, Issue 1
Dynamics of NRTI Resistance Mutations
during Therapy Interruption
Maria Trignetti
AIDS Research and Human Retroviruses Volume 25, Issue 1
Polymorphism, Recombination, and
Mutations in HIV Type 1 gag-Infecting
Peruvian Male Sex Workers
Carlos Augusto Yabar
AIDS Research and Human Retroviruses Volume 24, Issue 11
HIV Type 1 Subtype C Drug Resistance
among Pediatric and Adult South
African Patients Failing Antiretroviral
Therapy
Visva Pillay
AIDS Research and Human Retroviruses Volume 24, Issue 11
High Prevalence of Genetically Similar
HIV-1 Recombinants among Infected
Sex Workers in Nairobi, Kenya
Allison M Land
AIDS Research and Human Retroviruses Volume 24, Issue 11
High Divergence within the Major HIV
Type 1 Subtype B Epidemic in Panama
Sara Ahumada-Ruiz
AIDS Research and Human Retroviruses Volume 24, Issue 11
First Observation of HIV Type 1 Drug
Resistance Mutations in Algeria
Salima Bouzeghoub
AIDS Research and Human Retroviruses Volume 24, Issue 11
Identification of Subtype B, Multiple
Circulating Recombinant Forms and
Unique Recombinants of HIV Type 1 in
an MSM Cohort in China
Wanhai Wang
AIDS Research and Human Retroviruses Volume 24, Issue 10
Impact of Human Immunodeficiency
Virus Type 1 Reverse Transcriptase
Inhibitor Drug Resistance Mutation
Interactions on Phenotypic
Susceptibility
Vinod Trivendi
AIDS Research and Human Retroviruses Volume 24, Issue 10
Profile of HIV Type 1 Infection and
Genotypic Resistance Mutations to
Antiretroviral Drugs in Treatment-Naive
HIV Type 1-Infected Individuals in Hai
Phong, Viet Nam
Azumi Ishizaki
AIDS Research and Human Retroviruses February 2009, Issue 25, Volume 2
Genotypic Characterization of
CRF01_AE env Genes Derived from
Human Immunodeficiency Virus Type 1Infected Patients Residing in Central
Thailand
Piraporn Utachee
AIDS Research and Human Retroviruses February 2009, Issue 25, Volume 2
Apricitabine Does Not Select Additional
Drug Resistance Mutations in Tissue
Culture in Human Immunodeficiency
Virus Type 1 Variants Containing K65R,
M184V, or M184V plus Thymidine
Analogue Mutations
Maureen Oliveira
Antimicrobial Agents and Chemotherapy April 2009, Volume 53, Issue 4
SC29EK, a Peptide Fusion Inhibitor with
Enhanced -Helicity, Inhibits Replication
of Human Immunodeficiency Virus Type
1 Mutants Resistant to Enfuvirtide
Takeshi Naito
Antimicrobial Agents and Chemotherapy March 2009, Volume 53, Issue 3
Virologic Failure in First-Line Human
Immunodeficiency Virus Therapy with a
CCR5 Entry Inhibitor, Aplaviroc, plus a
Fixed-Dose Combination of LamivudineZidovudine: Nucleoside Reverse
Transcriptase Inhibitor Resistance
Regardless of Envelope Tropism
James F. Demarest
Antimicrobial Agents and Chemotherapy March 2009, Volume 53, Issue 3
Virologic Failure in Therapy-Naïve
Subjects on Aplaviroc plus LopinavirRitonavir: Detection of Aplaviroc
Resistance Requires Clonal Analysis of
Envelope
Kathryn M. Kitrinos
Antimicrobial Agents and Chemotherapy March 2009, Volume 53, Issue 3
Nucleoside and Nucleotide Analogs
Select in Culture for Different Patterns
of Drug Resistance in Human
Immunodeficiency Virus Types 1 and 2
Michel L Ntemgwa
Antimicrobial Agents and Chemotherapy February 2009, Volume 53, Issue 2
Both a Protective and a Deleterious
Role for the L76V Mutation
Tartaglia et al.
Antimicrobial Agents and Chemotherapy Volume 53
Drug Resistance Mutation Profile and
Accumulation Kinetics in Human
Immunodeficiency Virus-Positive
Individuals Infected with Subtypes B
and F Failing Highly Active
Antiretroviral Therapy Are Influenced by
Different Viral Codon Usage Patterns
A Waleria-Aleixo
Antimicrobial Agents and Chemotherapy December 2008, Volume 52, Issue 12
Genotypic Resistance Analysis of the
Virological Response to FosamprenavirRitonavir in Protease InhibitorExperienced Patients in CONTEXT and
TRIAD Clinical Trials
Anne-Genevieve Marcelin
Antimicrobial Agents and Chemotherapy December 2008, Volume 52, Issue 12
Darunavir Inhibitory Quotient Predicts
the 48-Week Virological Response to
Darunavir-Based Salvage Therapy in
Human Immunodeficiency VirusInfected Protease Inhibitor-Experienced
Patients
Jose Molto
Antimicrobial Agents and Chemotherapy November 2008, Volume 52, Issue 11
Virologic Response to LopinavirRitonavir-Based Antiretroviral
Regimens in a Multicenter International
Clinical Cohort: Comparison of
Genotypic Interpretation Scores
Philip Grant
Antimicrobial Agents and Chemotherapy November 2008, Volume 52, Issue 11
Are mutations in HIV type-1 reverse
transcriptase 245 codon predictive of
abacavir hypersensitivity reaction?
Laura Bracciale
Antiviral Therapy - 2009, Volume 14, Issue
1
Compilation and prevalence of
mutations associated with resistance to
non-nucleoside reverse transcriptase
inhibitors
Lotke Tambuyzer
Antiviral Therapy - 2009, Volume 14, Issue
1
Genetic barriers for integrase inhibitor
drug resistance in HIV type-1 B and
CRF02_AG subtypes
Almoustapha-Issiaka
Maïga
Antiviral Therapy - 2009, Volume 14, Issue
1
Broad advances in understanding HIV
resistance to antiretrovirals: report on
the XVII International HIV Drug
Resistance Workshop
Mark Mascolini
Antiviral Therapy - Volume 13, Issue 8
The status of HIV-1 resistance to
antiretroviral drugs in sub-Saharan
Africa
Raph L Hamers
Antiviral Therapy - Volume 13, Issue 8
Variability in the plasma concentration
of efavirenz and nevirapine is
associated with genotypic resistance
after treatment interruption
Laila Darwich
Antiviral Therapy - Volume 13, Issue 7
Raltegravir susceptibility and fitness
progression of HIV type-1 integrase in
patients on long-term antiretroviral
therapy
Maria Jose Buzon
Antiviral Therapy - Volume 13, Issue 7
HIV Drug Resistance Tests: An Update
on Methods for Calculating Phenotypic
Fold Change from a Viral Genotype
Nobel A. Bellosillo
Clinical Infectious Diseases - March 2009,
Volume 48, S2
Long-Term Trends of HIV Type 1 Drug
Resistance Prevalence among
Antiretroviral Treatment–Experienced
Patients in Switzerland
Viktor von Wyl
Clinical Infectious Diseases - April 2009,
Volume 48, Issue 7
HIV Drug Resistance Tests: An Update
on Methods for Calculating Phenotypic
Fold Change from a Viral Genotype
Nobel A Bellosillo
Clinical Infectious Diseases - March 2009,
Volume 48, Issue 5
Single-Dose Nevirapine to Prevent
Mother-to-Child Transmission of HIV
Type 1: Balancing the Benefits and
Risks
John W Mellors
Clinical Infectious Diseases - February
2008, Volume 48, Issue 4
Emergence of Multiclass Drug–
Resistance in HIV-2 in AntiretroviralTreated Individuals in Senegal:
Implications for HIV-2 Treatment in
Resouce-Limited West Africa
Clinical Infectious Diseases - February
2008, Volume 48, Issue 4
Geoffrey S Gottlieb
Persistent Minority K103N Mutations
among Women Exposed to Single-Dose
Nevirapine and Virologic Response to
Nonnucleoside Reverse-Transcriptase
Inhibitor–Based Therapy
Ashraf Coovadia
Clinical Infectious Diseases - February
2009, Volume 48, Issue 4
Persistent Minority K103N Mutations
among Women Exposed to Single-Dose
Nevirapine and Virologic Response to
Nonnucleoside Reverse-Transcriptase
Inhibitor–Based Therapy
Ashraf Coovadia
Clinical Infectious Diseases - February
2009, Volume 48, Issue 4
Emergence of Multiclass Drug–
Resistance in HIV-2 in AntiretroviralTreated Individuals in Senegal:
Implications for HIV-2 Treatment in
Resouce-Limited West Africa
Geoffrey S. Gottlieb
Clinical Infectious Diseases - February
2009, Volume 48, Issue 4
The Management of TreatmentExperienced HIV-Infected Patients: New
Drugs and Drug Combinations
Lucy E Wilson
Clinical Infectious Diseases - January
2009, Volume 48, Issue 2
Minority Quasispecies of DrugResistant HIV-1 That Lead to Early
Therapy Failure in Treatment-Naive and
-Adherent Patients
Karin J Metzner
Clinical Infectious Diseases - January
2009, Volume 48, Issue 2
Nonnucleotide Reverse-Transcriptase
Inhibitors and Treatment Interruption
Mark J DiNubile
Clinical Infectious Diseases - December
2008, Volume 47, Issue 12
Impact of reverse transcriptase
resistance on the efficacy of TMC125
(etravirine) with two nucleoside reverse
transcriptase inhibitors in protease
inhibitor-naïve, nonnucleoside reverse
transcriptase inhibitor-experienced
patients: study TMC125-C227
K Ruxrungtham
HIV Medicine - October 2008, Volume 9,
Issue 10
Drug resistance profiles for the HIV
integrase gene in patients failing
raltegravir salvage therapy
C Charpentier
HIV Medicine - October 2008, Volume 9,
Issue 9
Difference in drug resistance patterns
between minor HIV-1 populations in
cerebrospinal fluid and plasma
T Bergroth
HIV Medicine - January 2009, Volume 10,
Issue 2
Relationship of Injection Drug Use,
Antiretroviral Therapy Resistance, and
Genetic Diversity in the HIV-1 pol Gene
Kowalski, Jeanne
JAIDS - April 2009, Volume 50, Issue 4
Changes in Darunavir/r Resistance
Score After Previous Failure to
Tipranavir/r in HIV-1-Infected MultidrugResistant Patients
Spagnuolo, Vincenzo
JAIDS - February 2009, Volume 50, Issue
2
Prevalence of Drug-Resistant HIV-1 in
Rural Areas of Hubei Province in the
People's Republic of China
Luo, Minqi
JAIDS - January 2009, Volume 50, Issue 1
High Frequency of HIV-1 Dual Infections
Among HIV-Positive Individuals in
Cameroon, West Central Africa
Powell, Rebecca
JAIDS - January 2009, Volume 50, Issue 1
Envelope Coreceptor Tropism, Drug
Resistance, and Viral Evolution Among
Subtype C HIV-1-Infected Individuals
Receiving Nonsuppressive
Antiretroviral Therapy
Kassaye, Seble
JAIDS - January 2009, Volume 50, Issue 1
Development of Phenotypic HIV-1 Drug
Resistance After Exposure to SingleDose Nevirapine
Basson, Adriaan
JAIDS - December 2008, Volume 49,
Issue 5
National Survey for Drug-Resistant
Variants in Newly Diagnosed
Antiretroviral Drug-Naive Patients With
HIV/AIDS in South Korea: 1999-2005
Choi, Ju-veon
JAIDS - November 2008, Volume 49,
Issue 3
The Relationship Between Resistance
and Adherence in Drug-Naive
Individuals Initiating HAART Is Specific
to Individual Drug Classes
Tam, Lily W Y
JAIDS - November 2008, Volume 49,
Issue 3
The Impact of Different Definitions on
the Estimated Rate of Transmitted HIV
Drug Resistance in the United Kingdom
Green, Hannah
JAIDS - October 2008, Volume 49, Issue 2
Transmission Cluster of Multiclass
Highly Drug-Resistant HIV-1 Among 9
Men Who Have Sex With Men in
Seattle/King County, WA, 2005-2007
Buskin, Susan E
JAIDS - October 2008, Volume 49, Issue 2
Discordant genotypic interpretation and
phenotypic role of protease mutations
in HIV-1 subtypes B and G
Andre F Santos
Journal of Antimicrobial Chemotherapy January 2009, Volume 63, Issue 3
Mutations associated with virological
response to darunavir/ritonavir in HIV-1infected protease inhibitor-experienced
patients
Diane Descamps
Journal of Antimicrobial Chemotherapy Volume 63, Issue 3
High rate of early virological failure with
the once-daily
tenofovir/lamivudine/nevirapine
combination in naive HIV-1-infected
patients
D Rey
Journal of Antimicrobial Chemotherapy January 2009, Volume 63, Issue 2
Detection of low-frequency K103N
mutants after unstructured
discontinuation of efavirenz in the
presence of the CYP2B6 516 TT
polymorphism
Ana Garcia-Diaz
Journal of Antimicrobial Chemotherapy December 2008, Volume 62, Issue 6
Development and optimization of an
internally controlled dried blood spot
assay for surveillance of human
immunodeficiency virus type-1 drug
resistance
Andrew J Buckton
Journal of Antimicrobial Chemotherapy December 2008, Volume 62, Issue 6
HIV-2 integrase gene polymorphism and
phenotypic susceptibility of HIV-2
clinical isolates to the integrase
inhibitors raltegravir and elvitegravir in
vitro
B Roquebert
Journal of Antimicrobial Chemotherapy November 2008, Volume 62, Issue 5
Impact of gag mutations on selection of
darunavir resistance mutations in HIV-1
protease
Sidonie Lambert-Niclot
journal of Antimicrobial Chemotherapy November 2008, Volume 62, Issue 5
Prevalence of etravirine-associated
mutations in clinical samples with
resistance to nevirapine and efavirenz
J M Llibre
Journal of Antimicrobial Chemotherapy Volume 62, Issue 5
The antiherpetic drug acyclovir inhibits
HIV replication and selects the V75I
reverse transcriptase multidrug
resistance mutation.
McMahon MA
Journal of Biological Chemotherapy November 2008, Volume 283, Issue 46
Evolution of genotypic resistance to
enfuvirtide in HIV-1 isolates from
different group M subtypes
Kris Covens
Journal of Clinical Virology - April 2009,
Volume 44, Issue 4
HIV-1 drug resistance genotyping
quality assessment: Results of the
ENVA7 Genotyping Proficiency
Programme
A Pandit
Journal of Clinical Virology - December
2008, Volume 43, Issue 4
Tipranavir resistance associated
mutations in protease inhibitor-naïve
patients with HIV-1 subtype A/E
infection
Somnuek
Sungkanuparph
Journal of Clinical Virology - November
2008, Volume 43, Issue 3
Predicting the Response to
Combination Antiretroviral Therapy:
Retrospective Validation of
geno2pheno-THEO on a Large Clinical
Database
André Altmann
Journal of Infectious Diseases - April
2009, Volume 199, Issue 7
Low-Abundance Drug-Resistant HIV-1
Variants: Finding Significance in an Era
of Abundant Diagnostic and
Therapeutic Options
Robert W. Shafer
Journal of Infectious Diseases - March
2009, Volume 199, Issue 5
Low-Abundance Drug-Resistant Viral
Variants in Chronically HIV-Infected,
Antiretroviral Treatment–Naive Patients
Significantly Impact Treatment
Outcomes
Birgitte B. Simen
Journal of Infectious Diseases - March
2009, Volume 199, Issue 5
Improvement in the determination of
HIV-1 tropism using the V3 gene
sequence and a combination of
bioinformatic tools
Natalia Chueca
Journal of Medical Virology - Volume 81,
Issue 5
High prevalence of non-B HIV-1
subtypes in seamen and their sexual
partners in Croatia
Martha Kathleen
Ramirez-Piedad
Journal of Medical Virology - Volume 81,
Issue 4
Prediction of the virological response to
etravirine in clinical practice:
Comparison of three genotype
algorithms
Laurent Cotte
Journal of Medical Virology - Volume 81,
Issue 4
Genetic variability of human
immunodeficiency virus-1 in Bahia
state, Northeast, Brazil: High diversity
of HIV genotypes
Joana Paixao Monteiro
Journal of Medical Virology - Volume 81,
Issue 3
Selection of drug-resistant HIV-1 during
the early phase of viral decay is
uncommon in treatment-naïve patients
initiated on a three- or four-drug
antiretroviral regimen including
lamivudine
Tobias Bergroth
Journal of Medical Virology - Volume 81,
Issue 1
PL-100, a novel HIV-1 protease inhibitor
displaying a high genetic barrier to
resistance: An in vitro selection study
Serge Dandache
Journal of Medical Virology - Volume 80,
Issue 12
Natural polymorphisms in HIV-1
protease: Impact on effectiveness of a
first-line lopinavir-containing
Karen Champenois
Journal of Medical Virology - Volume 80,
Issue 11
antiretroviral therapy regimen
Characterization of a Human
Immunodeficiency Virus Type 1 V3
Deletion Mutation That Confers
Resistance to CCR5 Inhibitors and the
Ability To Use Aplaviroc-Bound
Receptor
Katrina M. Nolan
Journal of Virology - April 2009, Volume
83, Issue 8
The Human Immunodeficiency Virus
Type 1 Nonnucleoside Reverse
Transcriptase Inhibitor Resistance
Mutation I132M Confers
Hypersensitivity to Nucleoside Analogs
Zandrea Ambrose
Journal of Virology - April 2009, Volume
83, Issue 8
HR-2 Mutations in Human
Immunodeficiency Virus Type 1 gp41
Restore Fusion Kinetics Delayed by HR1 Mutations That Cause Clinical
Resistance to Enfuvirtide
Neelanjana Ray
Journal of Virology - April 2009, Volume
83, Issue 7
Non-Cleavage Site Gag Mutations in
Amprenavir-Resistant Human
Immunodeficiency Virus Type 1 (HIV-1)
Predispose HIV-1 to Rapid Acquisition
of Amprenavir Resistance but Delay
Development of Resistance to Other
Protease Inhibitors
Manabu Aoki
Journal of Virology - April 2009, Volume
83, Issue 7
Demonstration of Sustained DrugResistant Human Immunodeficiency
Virus Type 1 Lineages Circulating
among Treatment-Naïve Individuals
Stéphane Hué
Journal of Virology - March 2009, Volume
83, Issue 6
Human Immunodeficiency Virus Type 1
Population Genetics and Adaptation in
Newly Infected Individuals
M. Kearney
Journal of Virology - March 2009, Volume
83, Issue 6
In Vivo Fitness Cost of the M184V
Mutation in Multidrug-Resistant Human
Immunodeficiency Virus Type 1 in the
Absence of Lamivudine
Roger Paredes
Journal of Virology - February 2009,
Volume 83, Issue 4
Template Usage Is Responsible for the
Preferential Acquisition of the K65R
Reverse Transcriptase Mutation in
Subtype C Variants of Human
Immunodeficiency Virus Type 1
Dimitrios Coutsinos
Journal of Virology - February 2009,
Volume 83, Issue 4
Baseline Resistance of Primary Human
Immunodeficiency Virus Type 1 Strains
to the CXCR4 Inhibitor AMD3100
Jessamina E.Harrison
Journal of Virology - December 2008,
Volume 82, Issue 23
Minority Human Immunodeficiency
Virus Type 1 Variants in AntiretroviralNaive Persons with Reverse
Transcriptase Codon 215 Revertant
Mutations
Yumi Mitsuya
Journal of Virology - November 2008,
Volume 82, Issue 21
Resistance Mutations in Human
Immunodeficiency Virus Type 1
Integrase Selected with Elvitegravir
Confer Reduced Susceptibility to a Wide
Range of Integrase Inhibitors
Olivia Goethals
Journal of Virology - November 2008,
Volume 82, Issue 21
Selection of HIV Variants with Signature
Genotypic Characteristics during
Heterosexual Transmission
Manish Sagar
The Journal of Infectious Diseases February 2009, Volume 199, Issue 4
Phylogenetic Reconstruction of
Transmission Events from Individuals
with Acute HIV Infection: Toward MoreRigorous Epidemiological Definitions
Alison E Brown
The Journal of Infectious Diseases February 2009, Volume 199, Issue 3
Two-Months-off, Four-Months-on
Antiretroviral Regimen Increases the
Risk of Resistance, Compared with
Continuous Therapy: A Randomized
Trial Involving West African Adults
Christine Danel
The Journal of Infectious Diseases January 2009, Volume 199, Issue 1
Sensitivity of Phenotypic Susceptibility
Analyses for Nonthymidine Nucleoside
Analogues Conferred by K65R or M184V
in Mixtures with Wild-Type HIV-1
Mark R Underwood
The Journal of Infectious Diseases January 2009, Volume 199, Issue 1